Pulling SEC filings + quote and writing the call…

OS Therapies Inc
Next earnings ≈ Jul 5, 2026 · est. from filing cadence
Conservative balance sheet (liabilities/equity -1.95x).
OS Therapies Inc shows limited reported revenue.
Sources: SEC EDGAR (CIK 0001795091, latest 10-Q filed 2026-05-18) · as of 6/26/2026, 6:37:40 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | — | — | — |
| Gross profit | — | — | — |
| Operating income | -$4.34M | -$6.81M | -$28.7M |
| Net income | -$7.79M | -$8.88M | -$28.8M |
| Diluted EPS | -$1.46 | -$1.28 | -$0.98 |
| Net margin | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1047 tracked peers · median